Navigation Links
Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Date:6/1/2011

33

6.6.1 Market Driver: Technological Advancements is to Drive the Market 33

6.6.2 Market Restraint: High Risk associated with Stent to Restrain the Market 33

6.7 Aneurysm Clips: Market Characterization 34

6.7.1 Aneurysm Clips Market, Global, Revenue ($m), Historic, 2003-2010 34

6.7.2 Aneurysm Clips Market, Global, Revenue ($m), Forecast, 2010-2017 35

6.8 Aneurysm Clips: Market Dynamics 36

6.8.1 Market Driver: Cost of Treatment Is Driving the Market 36

6.8.2 Market Restraint: Advancements in the Treatment of Aneurysms is a Restraint to the Clipping Market 36

7 Interventional Neurology Market, by Country, Revenue ($m), 2003-2017 37

7.1 Interventional Neurology Market, The US, Revenue ($m), Historic, 2003-2010 37

7.2 Interventional Neurology Market, The US, Revenue ($m), Forecast, 2010-2017 38

7.3 Interventional Neurology Market, Canada, Revenue ($m), Historic, 2003-2010 39

7.4 Interventional Neurology Market, Canada, Revenue ($m), Forecast, 2003-2010 40

7.5 Interventional Neurology Market, The UK, Revenue ($m), Historic, 2003-2010 41

7.6 Interventional Neurology Market, The UK, Revenue ($m), Forecast, 2010-2017 42

7.7 Interventional Neurology Market, Germany, Revenue ($m), Historic, 2003-2010 43

7.8 Interventional Neurology Market, Germany, Revenue ($m), Forecast, 2010-2017 44

7.9 Interventional Neurology Market, France, Revenue ($m), Historic, 2003-2010 45

7.10 Interventional Neurology Market, France, Revenue ($m), Forecast, 2010-2017 46

7.11 Interventional Neurology Market, Italy, Revenue ($m), Historic, 2003-2010 47

7.12 Interventional Neurology Market, Italy, Revenue ($m), Forecast, 2010-2017 48

7.13 Interventional Neurology Market, Spain, Revenue ($m), Historic, 2003-2010 49

7.14 Interventional Neurology Market, Spain, Revenue ($m), Forecast, 2010-2017 50

7.15 Interventional Neurology Market, Japa
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Reportlinker Adds Chinas Guidebook for Pharmaceutical Patent Protection
2. Reportlinker Adds Greece Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017
3. Reportlinker Adds Global Top 10 Pharmaceutical Companies: Industry, Financial and SWOT Analysis
4. Reportlinker Adds the Future of In Vitro and In Vivo Diagnostic Integration
5. Reportlinker Adds Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018
6. Reportlinker Adds Epidemiology: Major Abdominal Surgery - A key risk factor for deep vein thrombosis and pulmonary embolism
7. Reportlinker Adds The Antibacterials Market Outlook to 2016
8. Reportlinker Adds The Global Pharmaceutical Fine Chemicals Market Outlook to 2015
9. Reportlinker Adds The Drug-Eluting Stent Market Outlook to 2016
10. Reportlinker Adds The Infusion Pump Market Outlook to 2016
11. Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)...  Sanofi (EURONEXT: SAN and NYSE: SNY ) ... , examining the selective JAK2 inhibitor SAR302503 for ... groups. The primary endpoint assessed the proportion of patients ... reported in previous trials, the most common adverse events ... be presented at an upcoming medical congress. ...
(Date:5/16/2013)... ZURICH , May 17, 2013 ... Research (A*STAR) and Switzerland,s Cytos Biotechnology ... dosed in a Phase 1 clinical trial with their H1N1 ... particle (VLP) technology. In this first Phase 1 clinical trial, ... its potential to protect against H1N1 influenza infection will be ...
(Date:5/16/2013)... N.C. , May 16, 2013  Today, the ... North Carolina House of Representatives recently approved ... for chemotherapy from charging patients higher out-of-pocket fees for ... formularies, many of which have more severe side-effects. However, ... limit of $300, which will continue to be a ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
... III study will evaluate effects of otelixizumab, an investigational anti-CD3 ... ... secretion, CAMBRIDGE, Mass., April 9, 2008 ... development of novel,therapies for immune-mediated diseases, today announced that it is,proceeding ...
... Calif., April 9, 2008 ,Poniard Pharmaceuticals, Inc. (Nasdaq: ... today announced that data from a Phase 2 ... patients with small,cell lung cancer (SCLC) will be ... Lung Cancer Conference in Geneva, Switzerland. The presentation ...
Cached Medicine Technology:Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 2Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 3Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 4Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference 2Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference 3
(Date:5/19/2013)... The Pradaxa lawyers at Bernstein Liebhard ... convened for hundreds of Pradaxa bleeding lawsuits ... U.S. District Court, Southern District of Illinois. According ... 14th, the Conference addressed the status of depositions and ... Conference that Defendants submitted a list of early trial ...
(Date:5/19/2013)... 19, 2013 Farming methods have changed ... the ground 10,000 years ago. Most recently, the Green ... by using genetically engineered seeds and by applying chemical ... backlash to these techniques due to the adverse environmental ... a corresponding surge in interest in organic, sustainable farming ...
(Date:5/19/2013)... WA (PRWEB) May 19, 2013 The Fat ... weight loss secrets that help people get in ... gender, and body shape. The program also is a natural ... diet plans. Besides, the author of this fat loss diet ... transformation program, which can help people keep body fat off ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Yeast infections are ... appear in sensitive areas of the human body. A new ... This new formula provides a unique method of application to ... spray solution is now provided to men and women searching ... naturally absorbed in the body through food and is stored ...
(Date:5/19/2013)... 19, 2013 Exciting new Skin Brushes ... reintroducing a great practice known through the ages but ... as dry body brushing, has so many benefits for ... Sublime Beauty®. "We love that circulation and lymphatic systems ... organ, the skin, is supported through Skin Brushing." , ...
Breaking Medicine News(10 mins):Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 2Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 3Health News:Weight Loss Secrets | How “The Fat Loss Code” Helps People Gain A Healthy Life And Get In Shape - Health Review 2Health News:A Safe & Homeopathic Yeast Infection Relief by Yeastrol Now Available at HealthCareSupplementz.com with Massive Discount 2Health News:Exciting New Skin Brushes at Sublime Beauty® Bring Health and Beauty Benefits; Celebrities and Models Know the Secret 2
... at Weill Cornell Medical College could prove a potent weapon ... called SS31, is able to cross the blood-brain barrier and ... damage. ,"In our experiments, we found that exposing ... a much smaller area of brain tissue being affected," says ...
... (WHO) has approved four new drugs manufactured by the Macleods ... one of the four would be used against some strains ... of these four medicines will reinforce efforts to scale up ... in a statement. ,The medicines are the first ...
... out that organically grown kiwifruit has more health benefits ... This study is reported in the SCI’s magazine Chemistry ... in January that consuming organic fruits was just a ... by Drs. Maria Amodio and Adel Kader, showed that ...
... up 21 community medical centres in 20 provinces. This is ... run by the state, many of which are overflowing with ... is also intended to bring improvements to medical services in ... has said that 13 centres will be built in the ...
... independent survey which was conducted in all mental health ... continue to remain in mixed wards//. This is much ... in 99% of hospitals. ,The healthcare commission ... sleeping accommodation or bathrooms with the opposite sex. This ...
... fatty acids docosahexaenoic acid (DHA) successfully reduced diastolic blood ... up previous results with higher doses. // ,"A ... likely to be of clinical significance with regard to ... lead author Hannah Theobald from King's College London. ...
Cached Medicine News:Health News:Antioxidant Molecule Could Help Minimize Stroke-Linked Brain Damage 2Health News:Indian Pharma Authorized to Market New Anti-TB Drugs 2Health News:organic kiwifruits promote health 2Health News:Hospital Projects to Take the Weight Off Overcrowded Ones 2Health News:Low-dose Omega-3 Linked to Lower Blood Pressure 2
... its wide orifice tip, the Finntip Wide ... suspensions and macromolecules like genomic DNA. This ... cell fragmentation. It is excellent for use ... model, the inside diameter of the orifice ...
... Packed conveniently in plastic-wrapped racks of 96 ... useno need to autoclave. Sterilized Diamond Tips ... sterilization and are delivered with a certificate ... Sterilized Diamond Tips are certified free of ...
... Finntips have been designed to optimize the ... of our tip products is widely recognized ... range has been extended over the years ... standard and special tips including filter tips, ...
This large orifice 1000 ul tips is the large volume alternative to MBP's 200G tip. Pipet fragile cells, viscous samples and genomic DNA with ease....
Medicine Products: